| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 15.05.
| Biotech Companies Look to Benefit From Transformed Patent System / Five Star Equities Provides Stock Research on Advanced Cell Technology and StemCells | | 20 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 05/15/12 -- In recent months the Biotech Industry has become a hotbed of Merger and Acquisition (M&A) activity and speculation. As large pharmaceuticals face major patent...
Mehr lesen zu:
Biotech Companies Look to Benefit From Transformed Patent System / Five Star Equities Provides Stock Research on Advanced Cell Technology and StemCells | |
| 12.04.
| Possible Bullish Inside Day Candle Pattern Detected for StemCells | | 6 | SmarTrend |
| 10.04.
| JOBS Act Allows Emerging Biotech Companies to Focus Funding on Research / Five Star Equities Provides Stock Research on Aastrom Biosciences, Inc. and StemCells, Inc. | | 49 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 04/10/12 -- One major problems in recent years for emerging biotech companies has been funding for research. With the signing of the Jumpstart Our Business Startups...
Mehr lesen zu:
JOBS Act Allows Emerging Biotech Companies to Focus Funding on Research / Five Star Equities Provides Stock Research on Aastrom Biosciences, Inc. and StemCells, Inc. | |
| 02.04.
| StemCells Down 6.3%, Shares Slide into the Red | | 6 | SmarTrend |
| 02.04.
| StemCells (STEM) Reports Encouraging Data for HuCNS-SC in PMD Patients | | 5 | StreetInsider.com |
| 02.04.
| StemCells' Milestone Clinical Trial in Pelizaeus-Merzbacher Disease Shows Evidence of Myelination Following Human Neural Stem Cell Transplantation | | 3 | Benzinga.com |
| 02.04.
| StemCells' Phase I Trial In PMD Shows Evidence Of Progressive Myelination | | 45 | AFX News |
| WASHINGTON (dpa-AFX) - StemCells, Inc. (STEM) revealed preliminary evidence
of progressive and durable donor-cell derived myelination in all four patients
who underwent transplantation with...
Mehr lesen zu:
StemCells' Phase I Trial In PMD Shows Evidence Of Progressive Myelination | |
| 15.03.
| STEMCELLS INC - 10-K, Annual Report | | 10 | SEC Filings |
| 13.03.
| StemCells Q4 Loss Narrows | | 58 | AFX News |
| WASHINGTON (dpa-AFX) - StemCells, Inc. (STEM) reported fourth-quarter net
loss of $7.2 million or $0.47 per share, narrower than the prior year's net loss
of $9.0 million or $0.70 per share.On...
Mehr lesen zu:
StemCells Q4 Loss Narrows | |
| 07.03.
| Will StemCells Walk The Talk? | | 67 | AFX News |
| WASHINGTON (dpa-AFX) - Stem cells have set the scientific world agog because
it has been proposed as candidates to treat a myriad of diseases ranging from
alzheimer's to arthritis, blindness...
Mehr lesen zu:
Will StemCells Walk The Talk? | |
| 15.02.
| Favorable News From Advanced Cell Technology and StemCells Inc Boosts Optimism in Regenerative Medicine Industry / The Paragon Report Provides Equity Research on Advanced Cell Technology & StemCells Inc. | | 64 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 02/15/12 -- Stem cell stocks have performed well of late, outperforming the S&P 500 by a large margin over the last three months. Since mid-November, TickerSpy's Stem...
Mehr lesen zu:
Favorable News From Advanced Cell Technology and StemCells Inc Boosts Optimism in Regenerative Medicine Industry / The Paragon Report Provides Equity Research on Advanced Cell Technology & StemCells Inc. | |
| 22.12.
| StemCells (STEM) Net $9.5M in Recent 16M Common, Warrant Offering | | 17 | StreetInsider.com |
| 16.12.
| StemCells (STEM) Prices 8M Unit, Series B Warrant Offering at $1.25/Unit | | 24 | StreetInsider.com |
| 15.12.
| StemCells Closes Enrollment Of First Cohort In Chronic Spinal Cord Injury Trial | | 55 | AFX News |
| WASHINGTON (dpa-AFX) - StemCells Inc. (STEM) announced that the first cohort
of the Company's Phase I/II clinical trial in chronic spinal cord injury have
been successfully transplanted...
Mehr lesen zu:
StemCells Closes Enrollment Of First Cohort In Chronic Spinal Cord Injury Trial | |
